Aripiprazole for prevention of delirium in the neurosurgical intensive care unit: a double-blind, randomized, placebo-controlled study.

Majid MokhtariMaryam FarasatinasabMina Jafarpour MachianMehdi YaseriMohammad GhorbaniSeyed Mahmood Ramak HashemiMehdi NikoobakhtNavid GolchinGholamhasan MohammadiMohammad Sistanizd

Published in: European journal of clinical pharmacology (2020)

Aripiprazole can reduce the incidence of delirium in the neurosurgical ICU. Studies with larger sample size in diverse ICU settings and longer follow-up are needed to confirm our findings.

Keyphrases

intensive care unit
double blind
mechanical ventilation
cardiac surgery
hip fracture
placebo controlled
open label
clinical trial
risk factors
phase iii
phase ii
acute kidney injury
acute respiratory distress syndrome
study protocol